Process-1st provides sales intelligence for pharma companies, mapping facility-level data into ranked, product-specific recommendations so reps know exactly what to sell before visiting a site. The platform combines detailed process maps, vendor portfolios, and AI-driven analysis to deliver site-specific intelligence reports and pre-call briefs. It covers all major biologics modalities and generates initial insights in under 48 hours.
Funding
Funding not disclosed
Founders
Product
Problem
Pharma sales representatives often know their quotas but rarely know which specific products a given manufacturing facility actually needs. Territory-level averages and guesswork lead to unfocused sales conversations, wasted calls, and missed opportunities at sites with distinct modalities, processes, and equipment profiles.
Solution
Process-1st delivers a sales intelligence platform that maps facility-level data into ranked, product-specific recommendations for bioprocess sales teams. The platform builds a detailed model of each customer site—including its modalities, processes, and equipment profile—and matches it against an industry-expert-built map of biologics manufacturing requirements. It derives which products from a vendor's portfolio are most likely needed at that specific siteched, ranked by confidence, and packaged into a Site Intelligence Report with a one-page pre-call brief. The system also provides competitor intelligence, portfolio gap analysis, and a SORA (Situation, Opportunity, Risk, Action) sales strategy for each account.
Target Audience
Primary customers are pharmaceutical and life sciences sales teams, particularly bioprocess sales representatives and account managers selling equipment, consumables, and reagents to biologics manufacturing facilities.
Features
- Site-level precision derived from facility-specific modalities, processes, and equipment profiles, not territory averages
- Product-specific signals ranked by likelihood of need at each individual site
- Intelligence Engine combining five layers of AI and data, including facility descriptions, detailed process maps, vendor portfolios, salesperson input, and a process-selling LLM
- Coverage of all major biologics modalities, including mAbs, biosimilars, microbials, bi-specifics, fusion proteins, and complex peptides
- Comprehensive Site Intelligence Reports with facility profile, pipeline analysis, process maps, competitor analysis, and incumbent vendor intelligence
- Sales Strategy (SORA) framework with ranked next steps and pre-call talking points tailored to each account's pipeline and timeline
- Ignition Services for bespoke engineering opportunities, providing concept-to-quote project execution
- Time to first insight under 48 hours, with signal accuracy of 94.2% on FDA-registered biologics sites